Serial Number | 97896222 |
Word Mark | TRINQUIS |
Filing Date | Wednesday, April 19, 2023 |
Status | 730 - FIRST EXTENSION - GRANTED |
Status Date | Tuesday, September 24, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, February 6, 2024 |
Goods and Services | Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications. Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
Translation of Words in Mark | The wording "TRINQUIS" has no meaning in a foreign language. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, May 15, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | TEVA PHARMACEUTICALS USA, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Party Name | TEVA PHARMACEUTICALS USA, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Event Date | Event Description |
Wednesday, January 3, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Saturday, April 22, 2023 | NEW APPLICATION ENTERED |
Monday, May 15, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, January 2, 2024 | ASSIGNED TO EXAMINER |
Wednesday, January 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, February 6, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, February 6, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, April 2, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, September 24, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, September 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, September 24, 2024 | SOU EXTENSION 1 GRANTED |
Tuesday, September 24, 2024 | SOU EXTENSION 1 FILED |